Estellore, Basilisa L.
HRN: 21-23-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/16/2022
04/23/2022
IV
4.5 G
Q8
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes